Research Article
Unraveling the Determinants of Protrusion Formation
Table 6
Effects of Rho kinase/myosin inhibitors on the prevalence of factor 5 featuresa.
| Tukey grouping | Mean | Combination of agents |
| A | | | | | 0.830 | H1152p, ROCK inhibitor (20.2 μM) | A | B | | | | 0.525 | SPC16524, MLC kinase inhibitor (680 μM) | A | B | C | | | 0.353 | H1152p (5.02 μM) | | B | C | D | | 0.072 | Control (PMA + LPA) | | | C | D | E | −0.195 | SPC16524 (170 μM) | | | C | D | E | −0.371 | Blebbistatin (0.8 μM) | | | | D | E | −0.405 | Control (untreated) | | | | | E | −0.592 | Blebbistatin (0.2 μM) |
|
|
aMeans with the same letter are statistically indistinguishable at the level .
|